Mironid is based in Glasgow, United Kingdom. It has raised $44M in total funding. Latest round: Series A.
Mironid funding overview
Mironid is based in Glasgow, United Kingdom. Mironid has raised $44M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2023. The round record for Mironid runs through 2023; nothing later has been disclosed. Investors on record include Roche Venture Fund, Epidarex Capital, Sofinnova Partners, BioGeneration Ventures, University of Strathclyde, Scottish Enterprise and 1 others. 7 distinct backers are named across the disclosed rounds.
Mironid at a glance
Total raised
$44M
Latest round
Series A
Latest round date
September 2023
Headquarters
Glasgow, United Kingdom
Notable investors
Roche Venture Fund, Epidarex Capital, Sofinnova Partners, BioGeneration Ventures, University of Strathclyde, Scottish Enterprise, European Investment Fund
Frequently asked about Mironid funding
How much has Mironid raised?
Mironid has raised $44M in total disclosed funding across the rounds on record.
Who has invested in Mironid?
Roche Venture Fund, Epidarex Capital, Sofinnova Partners, BioGeneration Ventures, University of Strathclyde, Scottish Enterprise are named among the investors backing Mironid.
What was the latest Mironid funding round?
The most recent disclosed round is a Series A, announced in September 2023.
Where is Mironid based?
Mironid is based in Glasgow, United Kingdom.
When did Mironid last raise?
The last disclosed Mironid round closed in September 2023 at Series A.
Mironid totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Glasgow below to benchmark round size and investor mix.
